메뉴 건너뛰기




Volumn 12, Issue 10, 2006, Pages 1464-1472

12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplantation recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus

(102)  Levy, Gary a   Grazi, Gian Luca b   Sanjuan, Fernando c   Wu, Youmin d   Mühlbacher, Ferdinand e   Samuel, Didier f   Friman, Styrbjorn g   Jones, Robert h   Cantisani, Guido i   Villamil, Frederico j   Cillo, Umberto k   Clavien, Pierre Alain l   Klintmalm, Goran m   Otto, Gerd n,ai   Pollard, Stephen o   McCormick, P Aiden p   Descalsi, V j   Gadano, A q   Villamil, A q   Angus, P r   more..


Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; AZATHIOPRINE; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

EID: 33750112891     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20802     Document Type: Article
Times cited : (90)

References (24)
  • 1
    • 33750117316 scopus 로고    scopus 로고
    • United Network for Organ Sharing Data Report: Liver Kaplan-Meier Graft Survival Rates for Transplants Performed 1996-2001
    • Available at: Accessed: February 2
    • United Network for Organ Sharing Data Report: Liver Kaplan-Meier Graft Survival Rates for Transplants Performed 1996-2001. Available at: http://www.optn.org. Accessed: February 2, 2004.
    • (2004)
  • 2
    • 0036776174 scopus 로고    scopus 로고
    • The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation
    • Vogt DP, Henderson JM, Carey WD, Barnes D. The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 2002; 132:775-780.
    • (2002) Surgery , vol.132 , pp. 775-780
    • Vogt, D.P.1    Henderson, J.M.2    Carey, W.D.3    Barnes, D.4
  • 4
    • 1642443425 scopus 로고    scopus 로고
    • Is there disparity between risk and incidence of cardiovascular disease after liver transplant?
    • Neal DA, Tom BD, Luan J, Wareham NJ, Gimson AE, Delrivere LD, et al. Is there disparity between risk and incidence of cardiovascular disease after liver transplant? Transplantation 2004;77:93-99.
    • (2004) Transplantation , vol.77 , pp. 93-99
    • Neal, D.A.1    Tom, B.D.2    Luan, J.3    Wareham, N.J.4    Gimson, A.E.5    Delrivere, L.D.6
  • 5
    • 0037068958 scopus 로고    scopus 로고
    • Tacrolimus versus microemulsified ciclosporin in liver transplantation: The TMC randomised controlled trial
    • O'Grady JG, Burroughs, Hardy P, Elbourne D, Truesdale A. Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial. Lancet 2002; 360:1119-1125.
    • (2002) Lancet , vol.360 , pp. 1119-1125
    • O'Grady, J.G.1    Burroughs2    Hardy, P.3    Elbourne, D.4    Truesdale, A.5
  • 6
    • 0035077104 scopus 로고    scopus 로고
    • Tacrolimus versus cyclosporin microemulsion in liver transplantation: Results of a 3-month study
    • European Liver Transplantation Tacrolimus vs Cyclosporin Microemulsion Study Group
    • Mühlbacher F.; European Liver Transplantation Tacrolimus vs Cyclosporin Microemulsion Study Group. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study. Transplant Proc 2001; 33:1339-1340.
    • (2001) Transplant Proc , vol.33 , pp. 1339-1340
    • Mühlbacher, F.1
  • 9
    • 2442595887 scopus 로고    scopus 로고
    • 2 monitoring of cyclosporine in de novo liver transplant recipients: The clinician's perspective
    • 2 monitoring of cyclosporine in de novo liver transplant recipients: the clinician's perspective. Liver Transpl 2004; 10: 577-583.
    • (2004) Liver Transpl , vol.10 , pp. 577-583
    • Villamil, F.1    Pollard, S.2
  • 11
    • 0142182744 scopus 로고    scopus 로고
    • Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes
    • Watashi K, Hijakata M, Hosaka M, Yamaji M, Shimotohno K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 2003; 38:1282-1288.
    • (2003) Hepatology , vol.38 , pp. 1282-1288
    • Watashi, K.1    Hijakata, M.2    Hosaka, M.3    Yamaji, M.4    Shimotohno, K.5
  • 13
    • 33750111763 scopus 로고    scopus 로고
    • Evaluation of the effect of immunosuppressive agents on hepatitis C: Cyclosporine reduces viral replication in the replicon model
    • [abstract]
    • Manir̀e T, Ethier C, Raymond VA, Andre A, Bilodeau M. Evaluation of the effect of immunosuppressive agents on hepatitis C: cyclosporine reduces viral replication in the replicon model [abstract]. Transplantation 2004;78(suppl1):13-14.
    • (2004) Transplantation , vol.78 , Issue.SUPPL. 1 , pp. 13-14
    • Manir̀e, T.1    Ethier, C.2    Raymond, V.A.3    Andre, A.4    Bilodeau, M.5
  • 14
    • 0028891442 scopus 로고
    • Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation
    • Sheiner PA, Schwartz ME, Mor E, Schulager LK, Theise N, Kishikawa K, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995;21:30-34.
    • (1995) Hepatology , vol.21 , pp. 30-34
    • Sheiner, P.A.1    Schwartz, M.E.2    Mor, E.3    Schulager, L.K.4    Theise, N.5    Kishikawa, K.6
  • 17
    • 33750121013 scopus 로고    scopus 로고
    • Immunosuppression with tacrolimus an absence of antihypertensive therapy are associated with fibrosis progression after hepatitis C virus (HCV) graft reinfection
    • International Society of Transplantation Congress 2002 [abstract 2652]
    • Duvoux C, Mennecier D, Pageaux G, Conti F, Roudot-Thoraval F, Dhumeaux D. Immunosuppression with tacrolimus an absence of antihypertensive therapy are associated with fibrosis progression after hepatitis C virus (HCV) graft reinfection. International Society of Transplantation Congress 2002 [abstract 2652]. Transplantation 2002;74(suppl).
    • (2002) Transplantation , vol.74 , Issue.SUPPL.
    • Duvoux, C.1    Mennecier, D.2    Pageaux, G.3    Conti, F.4    Roudot-Thoraval, F.5    Dhumeaux, D.6
  • 18
    • 0035660141 scopus 로고    scopus 로고
    • Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: Influence of immunosuppressive regimens
    • Hunt J, Gordon FD, Lewis WD, et al. Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: influence of immunosuppressive regimens. Liver Transpl 2001; 7:1056-1063.
    • (2001) Liver Transpl , vol.7 , pp. 1056-1063
    • Hunt, J.1    Gordon, F.D.2    Lewis, W.D.3
  • 19
    • 18444415726 scopus 로고    scopus 로고
    • Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients
    • Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002;36:202-210.
    • (2002) Hepatology , vol.36 , pp. 202-210
    • Berenguer, M.1    Prieto, M.2    San Juan, F.3    Rayon, J.M.4    Martinez, F.5    Carrasco, D.6
  • 20
    • 0033510546 scopus 로고    scopus 로고
    • Orthotopic liver transplantation for hepatitis C: Outcome, effect of immunosuppression, and causes of retransplantation duringan 8-year single-center experience
    • Ghobrial RM, Farmer DG, Baquerizo A, et al. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation duringan 8-year single-center experience. Ann Surg 1999;6: 824-833.
    • (1999) Ann Surg , vol.6 , pp. 824-833
    • Ghobrial, R.M.1    Farmer, D.G.2    Baquerizo, A.3
  • 22
    • 0028676540 scopus 로고
    • Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study
    • Ericzon B, Groth C, Bismuth H, Calne R, McMaster P, Neuhaus P, et al. Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study. Transplant Int 1994;7(suppl): Sll-S14.
    • (1994) Transplant Int , vol.7 , Issue.SUPPL.
    • Ericzon, B.1    Groth, C.2    Bismuth, H.3    Calne, R.4    McMaster, P.5    Neuhaus, P.6
  • 23
    • 0033855402 scopus 로고    scopus 로고
    • Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunosuppressive therapy by FK506/tacrolimus
    • Lohmann T, List C, Lamesch P, Kohlhaw K, Wenzke M, Schwarz C, et al. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunosuppressive therapy by FK506/tacrolimus. Exp Clin Endocrinol Diabetes 2000; 108:347-352.
    • (2000) Exp Clin Endocrinol Diabetes , vol.108 , pp. 347-352
    • Lohmann, T.1    List, C.2    Lamesch, P.3    Kohlhaw, K.4    Wenzke, M.5    Schwarz, C.6
  • 24
    • 7244247370 scopus 로고    scopus 로고
    • Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins)
    • Prasad GV, Kim SJ, Huang M, Kohlhaw K, Zaltzman JS, Fenton SS, et al. Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins). Am J Transplant 2004;4:1897-1903.
    • (2004) Am J Transplant , vol.4 , pp. 1897-1903
    • Prasad, G.V.1    Kim, S.J.2    Huang, M.3    Kohlhaw, K.4    Zaltzman, J.S.5    Fenton, S.S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.